Thermo Fisher Scientific Company Profile (NYSE:TMO)

About Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:TMO
  • CUSIP: 88355610
  • Web: www.thermofisher.com
Capitalization:
  • Market Cap: $77.58413 billion
  • Outstanding Shares: 390,119,000
Average Prices:
  • 50 Day Moving Avg: $190.66
  • 200 Day Moving Avg: $176.57
  • 52 Week Range: $139.07 - $194.43
P/E:
  • Trailing P/E Ratio: 33.77
  • Foreward P/E Ratio: 18.38
  • P/E Growth: 1.71
Sales & Book Value:
  • Annual Revenue: $19.2 billion
  • Price / Sales: 3.94
  • Book Value: $57.40 per share
  • Price / Book: 3.38
Dividend:
  • Annual Dividend: $0.60
  • Dividend Yield: 0.3%
Profitability:
  • EBITDA: $4.81 billion
  • Net Margins: 11.80%
  • Return on Equity: 15.97%
  • Return on Assets: 7.48%
Debt:
  • Debt-to-Equity Ratio: 0.68%
  • Current Ratio: 1.47%
  • Quick Ratio: 0.99%
Misc:
  • Average Volume: 1.44 million shs.
  • Beta: 1.05
  • Short Ratio: 1.66
 

Frequently Asked Questions for Thermo Fisher Scientific (NYSE:TMO)

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Wednesday, July 12th. Investors of record on Friday, September 15th will be paid a dividend of $0.15 per share on Monday, October 16th. This represents a $0.60 dividend on an annualized basis and a yield of 0.31%. The ex-dividend date is Thursday, September 14th. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc (NYSE:TMO) released its quarterly earnings results on Wednesday, July, 26th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.27 by $0.03. The company earned $5 billion during the quarter, compared to analysts' expectations of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company's revenue for the quarter was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.03 earnings per share. View Thermo Fisher Scientific's Earnings History.

When will Thermo Fisher Scientific make its next earnings announcement?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Thermo Fisher Scientific.

Where is Thermo Fisher Scientific's stock going? Where will Thermo Fisher Scientific's stock price be in 2017?

15 analysts have issued 1-year target prices for Thermo Fisher Scientific's stock. Their predictions range from $162.00 to $225.00. On average, they anticipate Thermo Fisher Scientific's stock price to reach $203.00 in the next twelve months. View Analyst Ratings for Thermo Fisher Scientific.

What are analysts saying about Thermo Fisher Scientific stock?

Here are some recent quotes from research analysts about Thermo Fisher Scientific stock:

  • 1. According to Zacks Investment Research, "Over the last three months, Thermo Fisher is trading above the broader industry. Thermo Fisher ended the second quarter on a promising note. We are particularly upbeat about the company gaining entry into the CDMO market through the recent acquistion of Patheon for $7.2 billion. We are also encouraged by the company’s series of product launches along with major progress in precision medicine initiatives. Thermo Fisher’s acquisition of FEI Company has already started to boost its analytical instruments portfolio. The company also opened Center of Excellence for electron microscopy in Saudi Arabia. The raised 2017 guidance is all the more encouraging indicating the fact that this overall bullish trend will continue through the year." (9/21/2017)
  • 2. Evercore ISI analysts commented, "When all is said in done we will remember 4Q as being generally uneventful, with guidance coming in better than feared as investors had become concerned re the impact from slowing biopharma demand (didn't really occur), mixed A&G trends and an incremental headwind from Fx. The level of consistency we see from TMO is unusual in this challenging healthcare environment and likely helps to justify valuation that is certainly not inexpensive on an EV / EBITDA basis (particularly in a rising rate world). That being said with so few places to hide in a difficult healthcare tape, we would expect TMO's superior EPS growth to help shares to remain a preferred equity, particularly given its status as a visible compounder. Thus despite today's sharp move in shares (up a bit more than we would have anticipated) we reiterate our Buy rating as risk / reward continues to be asymmetrically biased upward." (1/31/2017)

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:

  • Jim P. Manzi, Independent Chairman of the Board
  • Marc N. Casper, President, Chief Executive Officer, Director
  • Stephen Williamson, Chief Financial Officer, Senior Vice President
  • Mark P. Stevenson, Chief Operating Officer, Executive Vice President, President, Life Sciences Solutions
  • Seth H. Hoogasian, Senior Vice President, General Counsel, Secretary
  • Patrick M. Durbin, Senior Vice President, President - Specialty Diagnostics
  • Daniel P. Shine, Senior Vice President, President, Analytical Instruments
  • Peter E. Hornstra, Vice President, Chief Accounting Officer
  • Dion J. Weisler, Director
  • Nelson J. Chai, Independent Director

Who owns Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Diamond Hill Capital Management Inc. (0.28%), Hermes Investment Management Ltd. (0.16%), Douglas Lane & Associates LLC (0.09%), State Treasurer State of Michigan (0.09%), Alta Capital Management LLC (0.05%) and PGGM Investments (0.05%). Company insiders that own Thermo Fisher Scientific stock include Alan J Malus, C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Who sold Thermo Fisher Scientific stock? Who is selling Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Oakbrook Investments LLC, Douglas Lane & Associates LLC, Alta Capital Management LLC, State Treasurer State of Michigan, Bridges Investment Counsel Inc., Robeco Institutional Asset Management B.V. and Quantitative Systematic Strategies LLC. Company insiders that have sold Thermo Fisher Scientific stock in the last year include C Martin Harris, Daniel P Shine, Gregory J Herrema, Jim P Manzi, Marc N Casper, Peter E Hornstra, Peter M Wilver, Seth H Hoogasian, Stephen Williamson and Thomas W Loewald. View Insider Buying and Selling for Thermo Fisher Scientific.

Who bought Thermo Fisher Scientific stock? Who is buying Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was purchased by a variety of institutional investors in the last quarter, including Diamond Hill Capital Management Inc., Hermes Investment Management Ltd., Shell Asset Management Co., Assenagon Asset Management S.A., APG Asset Management N.V., Rockefeller Financial Services Inc., Carnick & Kubik Group LLC and FormulaFolio Investments LLC. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy Thermo Fisher Scientific stock?

Shares of Thermo Fisher Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of Thermo Fisher Scientific stock can currently be purchased for approximately $193.86.


MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)
Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  491 (Vote Outperform)
Underperform Votes:  223 (Vote Underperform)
Total Votes:  714
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Thermo Fisher Scientific (NYSE:TMO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 14 Buy Ratings
Consensus Rating:Buy (Score: 2.93)
Consensus Price Target: $203.00 (4.71% upside)
Consensus Price Target History for Thermo Fisher Scientific (NYSE:TMO)
Price Target History for Thermo Fisher Scientific (NYSE:TMO)
Analysts' Ratings History for Thermo Fisher Scientific (NYSE:TMO)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/9/2017Leerink SwannBoost Price TargetOutperform$190.00 -> $207.00N/AView Rating Details
9/28/2017Jefferies Group LLCReiterated RatingHold$195.00LowView Rating Details
9/26/2017Goldman Sachs Group, Inc. (The)Initiated CoverageBuy$225.00LowView Rating Details
9/25/2017Barclays PLCReiterated RatingOverweight$200.00 -> $215.00LowView Rating Details
9/10/2017Cowen and CompanyReiterated RatingOutperform$200.00 -> $220.00LowView Rating Details
9/6/2017Morgan StanleyReiterated RatingOverweight -> Overweight$220.00MediumView Rating Details
8/22/2017ArgusReiterated RatingBuyMediumView Rating Details
7/21/2017Bank of America CorporationReiterated RatingBuy$200.00 -> $210.00LowView Rating Details
7/20/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 -> $200.00LowView Rating Details
7/10/2017Citigroup Inc.Reiterated RatingBuy$182.00 -> $201.00LowView Rating Details
6/10/2017Deutsche Bank AGSet Price TargetBuy$200.00LowView Rating Details
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$194.00LowView Rating Details
4/28/2017BTIG ResearchBoost Price TargetBuy$180.00 -> $190.00LowView Rating Details
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 -> $162.00N/AView Rating Details
9/22/2016J P Morgan Chase & CoInitiated CoverageOverweight$180.00N/AView Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 -> $175.00N/AView Rating Details
3/2/2016Topeka Capital MarketsBoost Price TargetBuy$145.00 -> $155.00N/AView Rating Details
1/29/2016Stifel NicolausLower Price Target$158.00 -> $150.00N/AView Rating Details
1/29/2016KeyCorpLower Price TargetOverweight$152.00 -> $150.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$168.00N/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for Thermo Fisher Scientific (NYSE:TMO)
Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Earnings History by Quarter for Thermo Fisher Scientific (NYSE TMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$2.24N/AView Earnings Details
7/26/2017Q2 2017$2.27$2.30$4.92 billion$5.00 billionViewN/AView Earnings Details
4/26/2017Q1 2017$2.02$2.08$4.68 billion$4.77 billionViewN/AView Earnings Details
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Thermo Fisher Scientific (NYSE:TMO)
2017 EPS Consensus Estimate: $9.24
2018 EPS Consensus Estimate: $10.45
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$2.02$2.16$2.07
Q2 20173$2.22$2.27$2.25
Q3 20173$2.25$2.27$2.26
Q4 20173$2.61$2.69$2.66
Q1 20182$2.30$2.31$2.31
Q2 20182$2.55$2.58$2.57
Q3 20182$2.55$2.62$2.59
Q4 20182$2.97$3.02$3.00
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Thermo Fisher Scientific (NYSE:TMO)
Most Recent Dividend:10/16/2017
Annual Dividend:$0.60
Dividend Yield:0.31%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:10.45% (Trailing 12 Months of Earnings)
6.42% (Based on This Year's Estimates)
5.69% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Dividend History by Quarter for Thermo Fisher Scientific (NYSE TMO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/12/2017quarterly$0.150.33%9/14/20179/15/201710/16/2017
5/18/2017quarterly$0.150.35%6/13/20176/15/20177/17/2017
2/28/2017quarterly$0.150.38%3/13/20173/15/20174/17/2017
11/10/2016quarterly$0.150.4%12/13/201612/15/20161/16/2017
7/7/2016quarterly$0.150.39%9/13/20169/15/201610/17/2016
5/18/2016quarterly$0.150.4%6/13/20166/15/20167/15/2016
2/25/2016quarterly$0.150.46%3/11/20163/15/20164/15/2016
11/12/2015quarterly$0.150.45%12/11/201512/15/20151/15/2016
7/10/2015quarterly$0.150.45%9/11/20159/15/201510/15/2015
5/21/2015quarterly$0.150.45%6/11/20156/15/20157/15/2015
2/26/2015quarterly$0.150.46%3/12/20153/16/20154/15/2015
11/7/2014quarterly$0.150.51%12/11/201412/15/20141/15/2015
7/10/2014quarterly$0.150.51%9/11/20149/15/201410/15/2014
5/21/2014quarterly$0.156/12/20146/16/20147/15/2014
2/27/2014quarterly$0.150.48%3/13/20143/17/20144/15/2014
11/8/2013quarterly$0.150.61%12/12/201312/16/20131/15/2014
7/12/2013quarterly$0.150.68%9/12/20139/16/201310/15/2013
5/23/2013quarterly$0.150.69%6/13/20136/17/20137/15/2013
2/27/2013quarterly$0.150.81%3/13/20133/15/20134/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Thermo Fisher Scientific (NYSE:TMO)
Insider Ownership Percentage: 0.49%
Institutional Ownership Percentage: 83.32%
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/5/2017Peter E HornstraVPSell3,894$185.18$721,090.92View SEC Filing  
8/30/2017C Martin HarrisDirectorSell360$180.97$65,149.20View SEC Filing  
8/30/2017Daniel P ShineInsiderSell2,026$180.97$366,645.22View SEC Filing  
8/28/2017Seth H HoogasianVPSell4,140$177.80$736,092.00View SEC Filing  
8/18/2017Jim P ManziDirectorSell11,318$172.94$1,957,334.92View SEC Filing  
8/17/2017Jim P ManziDirectorSell1,000$175.20$175,200.00View SEC Filing  
8/2/2017Gregory J HerremaSVPSell30,000$176.02$5,280,600.00View SEC Filing  
6/5/2017Stephen WilliamsonCFOSell2,500$176.26$440,650.00View SEC Filing  
6/1/2017Marc N CasperCEOSell20,000$172.79$3,455,800.00View SEC Filing  
5/24/2017Daniel P ShineInsiderSell4,688$171.88$805,773.44View SEC Filing  
4/27/2017Thomas W LoewaldInsiderSell1,532$168.76$258,540.32View SEC Filing  
3/15/2017Marc N CasperCEOSell20,000$158.60$3,172,000.00View SEC Filing  
3/15/2017Peter M WilverVPSell9,079$160.73$1,459,267.67View SEC Filing  
3/10/2017Peter M WilverVPSell9,987$158.18$1,579,743.66View SEC Filing  
3/8/2017Thomas W LoewaldInsiderSell7,675$157.39$1,207,968.25View SEC Filing  
3/6/2017Seth H HoogasianVPSell3,142$158.71$498,666.82View SEC Filing  
3/6/2017Stephen WilliamsonCFOSell2,500$158.71$396,775.00View SEC Filing  
3/6/2017Thomas W LoewaldSVPSell4,049$158.71$642,616.79View SEC Filing  
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.72View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.60View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.68View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.96View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.00View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.70View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.00View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.00View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.00View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.00View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.00View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.00View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.00View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.00View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.00View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.00View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.25View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.00View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.00View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.00View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.00View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.00View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.00View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.34View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.00View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.00View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.00View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.85View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.50View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.35View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.00View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.12View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.50View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.48View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.88View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.00View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Thermo Fisher Scientific (NYSE:TMO)
Latest Headlines for Thermo Fisher Scientific (NYSE:TMO)
Source:
Loading headlines, please wait.

Social

Chart

Thermo Fisher Scientific (TMO) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.